Clearmind Medicine Inc. Common Shares (CMND) — Cash Flow-to-Debt Ratio
Clearmind Medicine Inc. Common Shares (CMND) has a Cash Flow-to-Debt Ratio of -0.72x as of January 2026, meaning its operating cash flow of $-2.08 Million could theoretically repay -1% of its total liabilities ($2.90 Million) in one year. See how financially flexible is Clearmind Medicine Inc. Common Shares to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Clearmind Medicine Inc. Common Shares Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Clearmind Medicine Inc. Common Shares across 12 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Clearmind Medicine Inc. Common Shares.
Annual Cash Flow-to-Debt Ratio for Clearmind Medicine Inc. Common Shares (2014–2025)
Year-by-year debt coverage analysis for Clearmind Medicine Inc. Common Shares.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.97x | $-4.73 Million | $4.89 Million | ▲ +17.4% |
| 2024 | -1.17x | $-6.76 Million | $5.77 Million | ▲ +7.6% |
| 2023 | -1.27x | $-6.30 Million | $4.97 Million | ▲ +34.2% |
| 2022 | -1.93x | $-5.06 Million | $2.62 Million | ▲ +73.3% |
| 2021 | -7.21x | $-2.08 Million | $288.19K | ▲ +63.6% |
| 2020 | -19.79x | $-198.50K | $10.03K | ▼ -1299.9% |
| 2019 | -1.41x | $-47.85K | $33.85K | ▲ +89.8% |
| 2018 | -13.82x | $-80.48K | $5.83K | ▼ -7665.7% |
| 2017 | -0.18x | $-9.12K | $51.28K | ▲ +42.1% |
| 2016 | -0.31x | $-15.37K | $50.01K | ▲ +83.2% |
| 2015 | -1.83x | $-39.81K | $21.76K | ▼ -105.2% |
| 2014 | -0.89x | $-28.01K | $31.43K | — |